ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email
Strong sales of Novo Nordisk’s Wegovy pill helped the company beat first‑quarter earnings expectations and raise its full‑year outlook. CNBC’s Ritika Gupta and Charlotte Reed break down the latest results and reflect on a turbulent year for the Danish pharma giant.
04:11
Wed, May 6 20267:53 AM EDT